Skip to main content
AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.41%KO-0.71%0700.HK-6.57%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK+0.05%ORCL-0.97%3988.HK-0.60%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.80%0857.HK-2.43%UNH-10.21%1288.HK-1.49%PM-0.85%0005.HK-2.03%NVS-2.46%INTC-0.91%HSBA.L-2.00%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.51%AUDUSD-1.44%AUDCAD-0.86%AUDNZD-0.86%EURAUD+0.85%AUDCHF-0.84%GBPAUD+0.79%GBPJPY-0.72%EURJPY-0.69%CHFJPY-0.67%NZDJPY-0.66%CADJPY-0.65%USDCHF+0.64%GBPUSD-0.64%EURUSD-0.61%USDCAD+0.60%NZDUSD-0.58%AUDSGD-0.49%USDZAR+0.45%GBPTRY+0.41%AUDDKK-0.41%USDTHB+0.35%GBPHKD+0.32%AUDNOK-0.31%NZDMXN+0.31%USDMXN+0.30%GBPMXN-0.28%EURZAR+0.28%USDNOK+0.26%GBPZAR+0.26%USDSEK+0.22%USDPLN+0.21%USDTRY+0.21%EURCNH-0.19%CHFNOK+0.17%EURHKD-0.17%USDDKK+0.17%USDILS+0.16%CHFSEK+0.13%NOKJPY-0.12%USDCNH-0.11%NZDSGD+0.11%EURNOK+0.10%GBPSGD-0.10%EURSGD-0.09%USDJPY-0.08%USDSGD+0.08%SGDJPY+0.07%GBPCAD-0.07%PLNJPY-0.07%EURSEK+0.06%GBPNZD-0.06%EURPLN+0.05%EURGBP+0.04%CADCHF+0.04%USDCOP-0.04%EURCZK+0.04%EURCHF+0.04%NZDCHF+0.03%EURNZD-0.03%CHFSGD-0.02%EURCAD-0.02%NZDCAD-0.01%USDHKD-0.01%GBPCHF0.00%EURDKK0.00%XPTUSD-0.68%XNGUSD-0.60%W1-0.47%UKOIL+0.42%C1-0.40%GAUUSD-0.28%XAUUSD-0.28%S1-0.24%XAGUSD-0.17%GAGUSD-0.17%HG1-0.12%USOIL+0.11%BTCUSD-2.78%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+1.03%ZECUSDT-5.36%XMRUSDT-1.52%DOGEUSD+55.95%LINKUSD-2.51%XLMUSD-3.01%BCHUSDT-2.75%LTCUSD+47.50%UNIUSD-2.19%SUIUSD-1.87%TONUSD+59.18%HBARUSDT-4.33%TAOUSDT-1.88%AAVEUSD-2.46%ONDOUSDT-3.78%ICPUSDT-1.61%DOTUSDT-2.96%WLDUSDT-2.45%ARBUSDT-4.84%ATOMUSDT-1.49%INJUSDT-6.37%STXUSDT-1.32%PYTHUSDT+1.09%TIAUSDT-1.70%FETUSDT-3.49%JUPUSDT+1.77%SEIUSDT-2.00%GRTUSDT-2.55%OPUSDT-2.63%IOTAUSDT-1.46%POLUSDT-1.33%WIFUSDT-2.25%AXSUSDT-2.04%EOSUSDT-3.45%IMXUSDT-3.36%FARTCOINUSDT-5.36%GALAUSDT-1.65%DYDXUSDT-1.92%ORDIUSDT-1.56%NOTUSDT+0.86%RONINUSDT-2.92%AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.41%KO-0.71%0700.HK-6.57%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK+0.05%ORCL-0.97%3988.HK-0.60%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.80%0857.HK-2.43%UNH-10.21%1288.HK-1.49%PM-0.85%0005.HK-2.03%NVS-2.46%INTC-0.91%HSBA.L-2.00%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.51%AUDUSD-1.44%AUDCAD-0.86%AUDNZD-0.86%EURAUD+0.85%AUDCHF-0.84%GBPAUD+0.79%GBPJPY-0.72%EURJPY-0.69%CHFJPY-0.67%NZDJPY-0.66%CADJPY-0.65%USDCHF+0.64%GBPUSD-0.64%EURUSD-0.61%USDCAD+0.60%NZDUSD-0.58%AUDSGD-0.49%USDZAR+0.45%GBPTRY+0.41%AUDDKK-0.41%USDTHB+0.35%GBPHKD+0.32%AUDNOK-0.31%NZDMXN+0.31%USDMXN+0.30%GBPMXN-0.28%EURZAR+0.28%USDNOK+0.26%GBPZAR+0.26%USDSEK+0.22%USDPLN+0.21%USDTRY+0.21%EURCNH-0.19%CHFNOK+0.17%EURHKD-0.17%USDDKK+0.17%USDILS+0.16%CHFSEK+0.13%NOKJPY-0.12%USDCNH-0.11%NZDSGD+0.11%EURNOK+0.10%GBPSGD-0.10%EURSGD-0.09%USDJPY-0.08%USDSGD+0.08%SGDJPY+0.07%GBPCAD-0.07%PLNJPY-0.07%EURSEK+0.06%GBPNZD-0.06%EURPLN+0.05%EURGBP+0.04%CADCHF+0.04%USDCOP-0.04%EURCZK+0.04%EURCHF+0.04%NZDCHF+0.03%EURNZD-0.03%CHFSGD-0.02%EURCAD-0.02%NZDCAD-0.01%USDHKD-0.01%GBPCHF0.00%EURDKK0.00%XPTUSD-0.68%XNGUSD-0.60%W1-0.47%UKOIL+0.42%C1-0.40%GAUUSD-0.28%XAUUSD-0.28%S1-0.24%XAGUSD-0.17%GAGUSD-0.17%HG1-0.12%USOIL+0.11%BTCUSD-2.78%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+1.03%ZECUSDT-5.36%XMRUSDT-1.52%DOGEUSD+55.95%LINKUSD-2.51%XLMUSD-3.01%BCHUSDT-2.75%LTCUSD+47.50%UNIUSD-2.19%SUIUSD-1.87%TONUSD+59.18%HBARUSDT-4.33%TAOUSDT-1.88%AAVEUSD-2.46%ONDOUSDT-3.78%ICPUSDT-1.61%DOTUSDT-2.96%WLDUSDT-2.45%ARBUSDT-4.84%ATOMUSDT-1.49%INJUSDT-6.37%STXUSDT-1.32%PYTHUSDT+1.09%TIAUSDT-1.70%FETUSDT-3.49%JUPUSDT+1.77%SEIUSDT-2.00%GRTUSDT-2.55%OPUSDT-2.63%IOTAUSDT-1.46%POLUSDT-1.33%WIFUSDT-2.25%AXSUSDT-2.04%EOSUSDT-3.45%IMXUSDT-3.36%FARTCOINUSDT-5.36%GALAUSDT-1.65%DYDXUSDT-1.92%ORDIUSDT-1.56%NOTUSDT+0.86%RONINUSDT-2.92%
MO

Moderna, Inc. (MRNA)

NASDAQ • Healthcare

$196.79
-$10.01 (-4.8%)
Market closed

Last close at November 18, 2026 at 21:00 UTC

Open$206.8
Day Range$196.52 - $208.68
Avg. Volume (3M)13.5M
Market Cap$79.6B
52 Week Range
$22.28$280.8
Next EarningsIn 85 daysFeb 12, 2027

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$1.3B100%
Gross Profitminus cost of goods$995M76%
Operating Incomeminus R&D and overhead$130M10%
Net Incomeminus taxes and the rest$162M12%

In plain terms: out of every $100 in revenue, Moderna, Inc. keeps $12 as net profit.

Fundamentals & Financials

Revenue (TTM)
$2.5B
Net Income (TTM)
-$2.7B
EPS (TTM)
-$7.08
ROA (TTM)
-20.71%
Current Ratio
3.62
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+23.6%Q2 2026-$3.4
+3.0%Q3 2026-$1.97
+134.5%Q4 2026$0.38
Next

Feb 12

in 85 daysQ1 2027

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +134.5%

Moderna’s revenue increased year over year in the third fiscal quarter of 2026, with sales up 29.2% to about $1.3 billion (from roughly $1.0 billion a year ago) in results reported November 6, 2026, reflecting continued commercialization of its mRNA vaccine and therapeutics platform across infectious disease and oncology programs. Operating cash flow was negative at about -$1.6 billion, indicating cash usage during the quarter. Consensus for the next period calls for EPS of -$1.73 on revenue of $675.4 million.

View full earnings history

About Moderna, Inc.

Moderna, Inc. develops and commercializes messenger RNA medicines and vaccines as a biotechnology company in healthcare, with $1.9 billion in revenue in FY2025. Listed on the NASDAQ Global Select Market under MRNA, the company applies its mRNA platform to preventive vaccines as well as therapeutic programs across infectious disease, oncology, and other treatment categories.

Name
Moderna, Inc.
CEO
Stéphane Bancel
Industry
Healthcare
Year Founded
2010
Employees
4,700

Today's Snapshot

AI-generated

The day ended with MRNA 4.8% lower at 196.79, in line with a weaker sector. Australia’s drug advisers added Moderna’s flu vaccines to a March review agenda.

Trading Volume

Below 10d avg (9.7M)

6.8M

vs S&P 500 Today

Strong Underperformance

-4.58%

Updated: November 18, 2026 at 21:18 UTC

Technical Indicators

3 Buy2 Neutral3 Sell
MRNA, trading around 196.79, displays a mixed technical picture with short- and medium-term averages positioned above the price while longer-term 100- and 200-day averages sit well below, creating conflicting signals. Short-term momentum is negative and several oscillators show oversold conditions, yet MACD remains neutral; ADX near 30 indicates a meaningful trend with bearish tilt and volatility is elevated with ATR around 9.5%. Cumulative volume trends are negative and the pivot sits above the market. Technical takeaway: neutral — near-term pressure is offset by longer-term support, producing a balanced technical outlook.
All signals
  • EMA (5 indicators)$116.72 - $224.16
    Sell
  • RSI (14)41.45
    Neutral
  • Stochastic %K (14, 3, 3)6.78
    Buy
  • MACD Level (12, 26)3.18
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.